Mario Gabelli Personalis, Inc. Transaction History

Gamco Investors, Inc. Et Al

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$7.65 - $14.11 $382,500 - $705,500	-50,000 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$4.75 - $12.41 $95,000 - $248,200	20,000 Added 66.67%	50,000 $404,000
Q3 2019 Nov 01, 2019	BUY	$14.16 - $25.34 $424,800 - $760,200	30,000 New	30,000 $440,000

22.6M

800

500

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $53.7M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.